Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)Product type:GuidanceProgramme:NICE guidelinePublished: 14 December 2023
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides (TA805)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 July 2022
MiraQ for assessing graft flow during coronary artery bypass graft surgery (HTG275)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 5 July 2022Published: 16 November 2011
HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography (HTG429)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 19 May 2021Published: 13 February 2017
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography (HTG571)Product type:GuidanceProgramme:HealthTech guidancePublished: 17 March 2021
Acute coronary syndromes (NG185)Product type:GuidanceProgramme:NICE guidelinePublished: 18 November 2020
Drug-eluting stents for the treatment of coronary artery disease (TA152)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 18 November 2020Published: 23 July 2008
Guidance on the use of coronary artery stents (TA71)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 18 November 2020Published: 22 October 2003
High-sensitivity troponin tests for the early rule out of NSTEMI (HTG552)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 August 2020
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease (TA607)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 October 2019
New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners (HTG281)Product type:GuidanceProgramme:HealthTech guidanceLast updated: 6 July 2017Published: 25 January 2012
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 December 2016
Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis (CG95)Product type:GuidanceProgramme:Clinical guidelineLast updated: 30 November 2016Published: 24 March 2010
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) (TA351)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome (TA335)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 March 2015
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (TA317)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 July 2014
Ticagrelor for the treatment of acute coronary syndromes (TA236)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 October 2011
Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction (TA73)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 July 2011Published: 26 November 2003
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (TA210)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 December 2010
Cardiovascular disease prevention (PH25)Product type:GuidanceProgramme:Public health guidelinePublished: 22 June 2010
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (TA47)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 1 March 2010Published: 5 September 2002
Cardiovascular disease: identifying and supporting people most at risk of dying early (PH15)Product type:GuidanceProgramme:Public health guidelinePublished: 24 September 2008
Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction (TA52)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 30 October 2002